August 20, 2014 12:54 PM ET

Biotechnology

Company Overview of Koronis Pharma, Inc.

Company Overview

Koronis Pharma, Inc., a biotechnology company, develops antiviral therapeutics based on Viral Decay Acceleration mechanism. It develops KP-1461 for the treatment of HIV virus; and products for the treatment of antiviral infections. The company was founded in 1998 and is based in Seattle, Washington.

500 Union Street

Suite 835

Seattle, WA 98101

United States

Founded in 1998

Phone:

206-682-1181

Fax:

206-682-8077

Key Executives for Koronis Pharma, Inc.

Consulting Chief Medical Director and Clinical & Scientific Advisor
Member of Clinical Advisory Board and Clinical & Scientific Advisor
Member of Clinical Advisory Board and Clinical & Scientific Advisor
Clinical & Scientific Advisor
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
JN-International Medical Corporation United States
Kaperio, Inc. United States
Andara Life Science, Inc. United States
Matinas Biopharma, Inc. United States
Ravgen, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
October 30, 2013
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Koronis Pharma, Inc., please visit www.koronispharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.